NCT06330818 Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients
| NCT ID | NCT06330818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Moyamoya Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2027-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-07-01 with a primary completion date of 2027-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of this study is to improve patient care in Moyamoya Patients by improving Imaging technologies and aiming to identify factors involved in disease progression. Main tasks are: * Analysis of CO2-triggered BOLD fMRI for analysis of cerebral hemodynamics in comparison to H2 15O PET/CT * Analysis of longitudinal changes of contrast enhancement in vessel-wall imaging and correlation of disease activity with biosampling * Definition of a standardized recommendation for pre- and postoperative imaging of Moyamoya patients
Eligibility Criteria
Inclusion Criteria: * Patients with suspicion of Moyamoya Disease * Patients able to understand the study and to give their informed consent Exclusion Criteria: * Cerebral vascular disease caused by atherosclerosis * Vasculitis * Contraindications to MRI * Contraindications to PET/CT * Pregnancy * Inability to give informed consent * Renal insufficiency
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06330818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Moyamoya Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06330818 currently recruiting?
Yes, NCT06330818 is actively recruiting participants. Contact the research team at constantin.roder@med.uni-tuebingen.de for enrollment information.
Where is the NCT06330818 trial being conducted?
This trial is being conducted at Tübingen, Germany.
Who is sponsoring the NCT06330818 clinical trial?
NCT06330818 is sponsored by University Hospital Tuebingen. The trial plans to enroll 50 participants.